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To identify novel genes involved in early development, and as proof-of-principle of a large-scale reverse genetics
approach in a vertebrate embryo, we have carried out an antisense morpholino oligonucleotide (MO) screen in Xenopus
tropicalis, in the course of which we have targeted 202 genes expressed during gastrula stages. MOs were designed to
complement sequence between  80 and þ25 bases of the initiating AUG codons of the target mRNAs, and the
specificities of many were tested by (i) designing different non-overlapping MOs directed against the same mRNA, (ii)
injecting MOs differing in five bases, and (iii) performing ‘‘rescue’’ experiments. About 65% of the MOs caused X.
tropicalis embryos to develop abnormally (59% of those targeted against novel genes), and we have divided the genes
into ‘‘synphenotype groups,’’ members of which cause similar loss-of-function phenotypes and that may function in
the same developmental pathways. Analysis of the expression patterns of the 202 genes indicates that members of a
synphenotype group are not necessarily members of the same synexpression group. This screen provides new insights
into early vertebrate development and paves the way for a more comprehensive MO-based analysis of gene function in
X. tropicalis.
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Introduction
The results of genome sequencing projects and the
extensive analyses of expressed sequence tags (ESTs) have
provided remarkable insights into the expression and
regulation of many genes. For some species, and especially
for invertebrates such as Caenorhabditis elegans and Drosophila
melanogaster, it has also been possible to assign functions to
these genes on a genome-wide scale. Such approaches have
frequently employed traditional genetic approaches [1], but
in addition, RNA interference (RNAi) has been used to
inhibit gene function in a systematic and high-throughput
manner in C. elegans [2,3] and Drosophila [4,5], while antisense
morpholino oligonucleotides (MOs) have been used in a
screen for gene function in the ascidian species Ciona
intestinalis [6].
‘‘Reverse genetic’’ screens of these sorts have the advantages
of speed (because one does not have to locate the mutated
gene) and economy, and a similar high-throughput approach
to the investigation of gene function in vertebrate embryos
will be very important for a proper understanding of
development and disease. Unfortunately, such an approach
cannot easily be adopted inmammalian embryos, except when
studying very early stages [7], because the embryos are
inaccessible and the abilities of most reagents to inhibit gene
function decline as the embryos grow. Zebraﬁsh provide a
useful and powerful alternative, and indeed quite extensive
MO screens have been carried out in this species [8]. However,
the zebraﬁsh is not a tetrapod, and like other teleost ﬁsh it
underwent a whole genome duplication event between 200
and 450 million years ago [9,10], so that some genes are likely
to have retained at least partially redundant functions [11,12].
In this paper we show that the tetrapod species Xenopus
tropicalis is a useful alternative model organism. X. tropicalis
shares most of the advantages of Xenopus laevis as a model
system for studying cellular, molecular, and developmental
biology [13,14], and it shows a higher degree of synteny to
amniotes than does the zebraﬁsh (see http://www.metazome.
net). In addition to these advantages, X. tropicalis is diploid (X.
laevis is allotetraploid), its genome has been sequenced (http://
genome.jgi-psf.org/Xentr4/Xentr4.home.html), it develops
more quickly than X. laevis, and it has a generation time of
approximately 5 months compared with that of 14 months in
X. laevis.
The technique of choice for inhibiting gene function in
Xenopus species involves the injection of MOs [15]. MOs are
frequently designed to inhibit translation of the target mRNA
but can also be used to interfere with the correct splicing of a
target pre-mRNA [16,17]. It is important to note that MOs,
like RNAi, do not necessarily remove the gene product of
interest completely, so the strategy is referred to as gene
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offer the opportunity to study the functions of large numbers
of vertebrate genes very quickly compared with the gen-
eration of genetic null mutants, and indeed a pilot screen in
X. tropicalis, in which the functions of 26 genes were
investigated, suggests that this approach might be fruitful
[18].
In this paper we use MOs to inhibit the functions of 202
genes in X. tropicalis. We have addressed the speciﬁcity of the
different MOs, assigned the observed phenotypes to different
classes, and, as Niehrs and colleagues have done for gene
expression patterns [19,20], subdivided the phenotypic classes
into synphenotype groups [21]. Work in Drosophila [1] and the
zebraﬁsh [22,23] has shown that the classiﬁcation of pheno-
types in this way is fundamental to the analysis of develop-
ment, allowing the identiﬁcation of genes that are involved in
similar developmental processes and which interact with each
other genetically or biochemically, directly or indirectly. The
expression pattern of each gene has been analyzed by in situ
hybridization and by noting the representation of its
associated transcripts in different cDNA libraries. All the
data are accessible through a Web-based database, and our
data pave the way for a more comprehensive MO-based
analysis of gene function in X. tropicalis.
Results
Gene Selection and Experimental Conditions
Genes were selected for analysis from the Wellcome Trust/
CR-UK Gurdon Institute Xenopus tropicalis database (http://
informatics.gurdon.cam.ac.uk/online/xt-ﬂ-db.html) [24].
BLAST searching conﬁrmed one of our criteria that all
should be conserved between Xenopus and mammals, and in
addition, for purposes of comparison, we selected some genes
that had been studied previously by mutation, knockdown, or
dominant-negative technologies, and some that had not. The
former category allows the comparison of phenotypes caused
by injection of MOs in X. tropicalis with those obtained by
other approaches in other species, including mouse and
zebraﬁsh, as well as X. laevis. The latter category was divided
into one group comprising genes about which at least
something is known (for example, that they are members of
gene families already known to play a role in development, or
have been studied in vitro, or contain a particular functional
domain) and another comprising genes that are completely
novel. A large proportion of genes identiﬁed through genome
and EST sequencing projects are of unknown function, so
analysis of this second group should provide an idea of what
results might be obtained in the course of a screen designed
to target the entire X. tropicalis transcriptome.
Unless otherwise stated, MOs were designed to comple-
ment sequence between  80 and þ25 bases of the initiating
AUG codon of the target mRNA (see Materials and Methods).
Two different doses of MO were injected for each gene
studied. First, like Kenwrick and colleagues [18], who also
used X. tropicalis, we injected 10–15 ng of our oligonucleo-
tides. However, we also noted that experiments in X. laevis can
employ up to 90 ng MO [25] and that the signiﬁcantly smaller
embryos of X. tropicalis contain between a third to half as
much RNA as those of X. laevis (unpublished data). Our results
also show that 30 ng of a control MO causes no detectable
effect on the development of X. tropicalis, beyond, in some egg
batches, a slight delay in development. In an attempt to strike
a balance between eliminating the gene product of interest
and not causing non-speciﬁc effects, we therefore addition-
ally used a dose of 30 ng MO in our experiments.
Overview
Embryos were examined at early to mid-gastrula (stage
10.5–12), tailbud (stage 22–28), and tadpole (stage 37–41)
stages (Figure 1A–1C), and any deviations from normal
development at each stage were noted (see below). MOs were
modiﬁed by the addition of Carboxyﬂuorescein or Lissamine
at their 39 ends, allowing us to ensure that oligonucleotides
were distributed evenly throughout the embryo and, to some
extent, that similar amounts of MO had been injected into
each embryo (Figure 1D–1F). Higher-power examination of
the animal pole region of an embryo at the early gastrula
stage revealed that ﬂuorescent MOs are present in both the
nucleus and the cytoplasm of cells, but are particularly highly
concentrated in the nucleus (Figure 1D’).
Table 1 provides an overview of the results obtained in this
screen. For the purposes of this analysis we require that a
particular MO should cause at least 50% of injected embryos
Table 1. Summary of Results
Gene Category
a % Phenotypes Observed
10–15 ng 30 ng
All genes (n ¼ 202) 63 (48) 69
Previously studied (n ¼ 70) 77 (57) 79
Partially characterized (n ¼ 64) 56 (48) 61
Novel (n ¼ 68) 54 (38) 59
aSee text for definitions of these categories.
Figures in parentheses in the center column indicate the frequency of phenotypes
observed when analysis is carried out at stage 30 and not tadpole stage 37–41.
doi:10.1371/journal.pgen.0020193.t001
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Synopsis
Genome sequencing projects have provided remarkable insights
into the expression and regulation of many genes. For some species,
such as the invertebrates Caenorhabditis elegans and Drosophila
melanogaster, it has been possible to assign functions to these
genes on a genome-wide scale. For the vertebrates, similar efforts
are being made in mouse and zebrafish, but work in the former
species is expensive and slow, and the zebrafish experienced a
whole genome duplication event, so that some genes may have
retained redundant functions. Here, this study uses antisense
morpholino oligonucleotides (MOs) to show that the diploid
amphibian Xenopus tropicalis provides a powerful alternative
species. The authors have designed MOs to target sequences
around the initiating AUG codons of 202 genes expressed during
early development and confirmed that these function in a specific
manner. About 65% of the MOs caused embryos to develop
abnormally, and the authors have divided the genes into
‘‘synphenotype groups,’’ members of which cause similar loss-of-
function phenotypes. Expression pattern analysis indicates that
members of a synphenotype group are not necessarily members of
the same synexpression group. This screen provides new insights
into vertebrate development and paves the way for a comprehen-
sive MO-based analysis of gene function in X. tropicalis.(n   40) to develop in a similar abnormal fashion if the MO is
to be classiﬁed as yielding a phenotype. In practice, and as
described below, our results show that the results obtained at
the two doses of MO used in these experiments are similar,
and that the ‘‘penetrance’’ of the MOs is usually uniform and
high. For example, of the 135 oligonucleotides that yield a
phenotype following injection of 30 ng MO, 96% (127)
yielded a phenotype following injection of 10 ng. At this
lower concentration, 105 of the 127 (83%) showed 100%
penetrance (that is, all the embryos developed in a speciﬁc
abnormal fashion) and 22 (17%) displayed a phenotype in
50%–99% of cases.
Together, these observations suggest that a dose of 10–15
ng MO will usually be sufﬁcient to inhibit gene function,
although for 4% of the genes screened a phenotype was only
observed at the higher dose. In six of these eight cases the
penetrance at 30 ng MO was between 80% and 100%.
Each MO was injected on three independent occasions
(twice at 10–15 ng and once at 30 ng), and in every case the
same phenotype was observed (except in those cases when a
phenotype was only observed at 30 ng MO). These observa-
tions suggest that the phenotypes are due to gene-speciﬁc
effects of the MOs and not, for example, to the injection
procedure, and that the results are not inﬂuenced signiﬁ-
cantly by genetic variation between the outbred individuals
used in these experiments (see Materials and Methods).
The genes studied fell into three classes (see above). For
those whose functions have been previously studied, our MOs
caused phenotypes in 77% (10–15 ng MO) and 79% (30 ng
MO) of cases (n ¼ 70; Table 1). For genes that have been
partially characterized (that is, they are previously unstudied
members of known gene families, or they have only been
studied in vitro, or their protein products contain a known
functional domain), our MOs caused phenotypes in 56% (10–
15 ng) and 61% (30 ng) of cases (n ¼ 64; Table 1). Finally, for
‘‘novel’’ genes, we observe a phenotype in 54% (10–15 ng) and
59% (30 ng) of cases (n ¼ 68; Table 1).
MO Specificity: Theoretical and Experimental
Considerations
How speciﬁc are the phenotypes we observe? At the end of
this paper we address this point experimentally for a group of
MOs that causes defects in gastrulation, but some general
comments are necessary before describing the results we
obtain. First, it is unlikely that our MOs exert toxic effects,
because injection of 30 ng of a standard control MO has little
or no effect on development (see, for example, Figure 2A, 2D,
and 2G), and of the 262 MOs injected in the course of this
work (some of which are ‘‘second site’’ MOs and excluding the
additional MOs, see below), 89 have no effect on development
(other than occasionally causing a slight delay) even at the
higher dose of 30 ng (Table 1). We also note that MOs that are
altered by ﬁve bases from their target sequences have little or
no effect on development.
In addition, we have asked whether the MOs that are
targeted against speciﬁc mRNAs complement sequences
elsewhere in the X. tropicalis genome. In our experience (see
below and also http://www.gene-tools.com), 25-mer MOs that
differ in ﬁve nucleotides from the target sequence have no
effect on the translation of the mRNA in question, so our
analysis ignores sequences that differ by more than four
nucleotides from a perfect match.
Theoretical calculations based on this criterion and the
existing X. tropicalis genome assembly suggest that the
probability of there being an additional MO target sequence
within the vicinity of the translation start site of an mRNA is
as high as 0.3 (unpublished data). This can be extended to
allow for the possibility of additional interactions with
intron-exon splice sites. If we assume that an ‘‘average’’ gene
has seven exons, and that the morpholino must be centered
within two or three bases of the splice site to be effective,
Figure 1. Embryos of X. tropicalis at the Stages Examined for Abnormalities Caused by Injection of MOs
Embryos had been injected at the one-cell stage with a Lissamine-labeled control MO.
(A–C) Bright field views. (D–F) Fluorescent views. D’ shows a high-power view of cells within the animal hemisphere of an embryo at the early gastrula
stage.
(A and D) Early gastrula stage 10–11. (B and E) Tailbud stage 28. (C and F) Tadpole stage 41.
doi:10.1371/journal.pgen.0020193.g001
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Morpholino Screen in X. tropicalisthen this might extend the search space by (say) seven bases
per exon. This would add 70 bases of search space per gene to
the original 100 bases used around the translation start site,
and would therefore increase the probability to ;0.5. We
note, however, that the efﬁcacies of MOs with this degree of
mismatch are likely to be signiﬁcantly lower than those of
MOs showing a perfect match, and that these efﬁcacies will
also depend on factors such as the GC content of the target
sequence and the location of the mismatches within the MO.
We also note that as the criteria applied become more
stringent, the probability of an MO matching an additional
sequence elsewhere in the genome becomes much smaller.
For example, the probability of there being an additional MO
target sequence near the translation start site that differs by
up to three nucleotides from a perfect match (rather than
four) is approximately 0.003.
Searches for additional target sequences of our MOs by
BLAST analyses of the X. tropicalis transcriptome are
confounded by the incomplete nature of the genome, but
searches of three datasets gave similar results, and the
combined results from all three should set a reliable lower
limit to the extent of non-speciﬁc effects of our MOs. The
three datasets were (i) the complete set of Ensembl transcripts
for X. tropicalis, (ii) the X. tropicalis genome sequence
combined with Ensembl/JGI gene models, and (iii) EST
clusters that include the complete predicted 59 UTR. Of the
202 MOs used in this paper, we found that only 14 (6.9%)
complement at least 21 out of 25 bases within the 59 UTR of
additional known or predicted open reading frames (Table 2);
and of these most differ in three or four rather than one or
two bases. For a further 13 MOs we could not decide whether
the MO was targeting an additional gene or whether this was
the intended target, perhaps obscured by sequencing errors.
In the future it will be helpful to have a tool such as AMOD
[26] to help in the design of X. tropicalis MOs.
It is possible to test the speciﬁcity of the phenotype
induced by a particular MO experimentally in several ways
[17]. One is to perform a ‘‘rescue’’ experiment, in which the
MO is co-injected with a form of the target mRNA that lacks
the MO-binding site. This approach is labor-intensive, and
attempts to rescue the phenotype can often fail even when
the phenotype is speciﬁc. This may occur, for example, if the
targeted gene is expressed in a restricted manner and the
presence of the gene product elsewhere in the embryo causes
an over-expression phenotype [27]. Successful rescue may
also depend on the concentration of rescuing RNA [28]. We
have only adopted this approach to investigate the speciﬁc-
ities of the MOs that lead to defects in gastrulation (see
below).
The second approach is to target the gene in question by
means of a second MO that complements a sequence
different from that recognized by the ﬁrst. In this paper,
Figure 2. Examples of the Similarities between Phenotypes Caused by Second Site MOs and Those of the Primary MO Directed against Sequence
around the Translation Start Site of the Target mRNA
(A–C) MOs directed against 14-3-3g. (A) Control MO; embryos develop normally.
(B) Embryos injected with MO1, directed against the translation start site of 14-3-3g, develop with a shortened antero-posterior axis.
(C) Embryos injected with MO2, directed against sequence 59 of the translation start site of 14-3-3g, resemble those injected with MO1.
(D–F) MOs directed against Xnr3. (D) Control MO; embryos develop normally. (E) Embryos injected with MO1, directed against the translation start site
of Xnr3, exhibit an upturned tail. (F) Embryos injected with MO2, directed against sequence 59 of the translation start site of Xnr3, also have an upturned
tail, but they differ slightly from those injected with MO1 because their antero-posterior axes are slightly shortened.
(G–J) MOs directed against Tbx3. (G and I) Embryos injected with control MOs develop normally. (H) Embryos injected with MO1, directed against the
translation start site of Tbx3, have a normal body axis but their tails are slightly wavy. (J) Embryos injected with MO2, directed against sequence 59 of
the translation start site of Tbx3, have a more severe phenotype than those injected with MO1, in which the antero-posterior axis of the embryo is
shortened. MO1, primary MOs; MO2, second site MOs.
doi:10.1371/journal.pgen.0020193.g002
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sequence 59 of the ﬁrst MO; that is, further upstream in the 59
UTR. If these second MOs cause a similar phenotype, one can
be more conﬁdent that this is a speciﬁc effect of the loss of
the target protein.
Excluding our detailed examination of the speciﬁcities of
the MOs that lead to gastrulation defects (see below), second
site MOs were designed for 48 of the genes which, when
targeted by the ﬁrst MO, resulted in abnormal development.
Of these MOs, 34 yielded a phenotype following injection
into embryos of X. tropicalis. In most cases (n ¼ 21), the
phenotypes resembled those caused by the ﬁrst MO. In others
the phenotype appeared to be a less severe version of that
caused by the ﬁrst MO; in only one case (Wnt5b) did the two
phenotypes appear strikingly different. Second site MOs were
also designed to recognize 12 genes that when targeted by the
ﬁrst MO did not result in a disruption of development. In
seven cases no phenotype was observed with the second MO,
but ﬁve of the second site MOs did cause embryos to develop
abnormally (Table 3). As we discuss below, these results,
together with the observation that injection of control MOs
yields no phenotype, suggest that the effects of our MOs are
usually speciﬁc.
The ﬁnal approach is to design MOs whose complement
differs from the target sequence in ﬁve nucleotides (see http://
www.gene-tools.com). This approach has been adopted to
investigate the speciﬁcities of the MOs that cause defects in
gastrulation (see below).
Expression Patterns, Phenotypic Classes, and
Synphenotype Groups
Niehrs and Pollet [20] have introduced the concept of a
‘‘synexpression group,’’ a set of genes that are all expressed in
a very similar pattern and are all believed to function in the
same developmental process. In this paper, in an analogous
manner, we have grouped the various phenotypes we observe,
in the hope that this too might help identify genes involved in
the same process. A similar approach has been adopted by
Chen and colleagues in describing the effects of over-
expressing genes in Xenopus embryos [21], and as described
above, the classiﬁcation of phenotypes in this way has long
been known to be an essential component of forward genetic
analyses of development [1,22,23].
Our initial classiﬁcation divided embryos into seven
phenotypic classes based on the time of embryonic lethality,
the length and shape of the main body axis, and, for the
seventh class, the ability to swim. The members of these
classes were then divided into 19 synphenotype groups
(Figure 3), each of which comprises genes whose loss-of-
function phenotypes resemble each other particularly closely.
This exercise may help in coming to understand how the
genes function, individually and collectively, in the gener-
ation of the early embryo.
We describe the seven phenotypic classes and their
subdivision into different synphenotype groups, below. These
results are summarized in Table 4 and illustrated in Figures
4–13. In some cases a gene that has been targeted by two
different MOs may appear in two different groups, because
the phenotype caused by the ﬁrst MO may be more or less
extreme than that caused by the second. In other cases it is
possible that a gene might be classiﬁed as belonging to more
than one synphenotype group, and this is indicated in the
third column of Table 4.
Table 2. Potential Alternative Targets of the MOs Used in This Paper
Wellcome Clone Identifier Gene Name Alternative Targets (Number of Mismatches)
Ensembl Transcripts Ensembl/JGI Gene Models EST Clusters
TEgg054m19 Serpin E2 — — 1 (1)
TEgg073l16 Rac1 2 (3,3) 2 (3,3) 3 (3,3,4)
TEgg078i06 Novel — — 1 (4)
TEgg096l10 CD2IC 1( 4 ) — —
TGas029e03 Cdc42 1 (4) 1 (4) 1 (4)
TGas050a15 CD2LC 1 (3) 1 (3) 1 (3)
TGas139h15 Novel — — 1 (0)
TGas144p20 Wnt11 ? — 1 (4)
TNeu074i11 ARP2/3 1a —8 ( 0 ...)1 1 ( 0 ...)
TNeu103f06 AHNAK — — 1 (4)
TNeu134e01 HoxB3 1( 4 ) ? —
TTpA004p03 14-3-3f/d 1 (4) ? 1 (4)
TTpA007k16 Smad5/8a — 1 (0) —
TTpA010k20 14-3-3beta 1 (4) — 1 (4)
Numbers indicate the number of potential additional target mRNAs found in each database; numbers in parentheses show the number of base mismatches. Question marks indicate cases
where doubt exists as to a match (see text). The large numbers of perfect matches in the case of TNeu074i11/ARP2/3 1a may be due to the presence of active transposable elements.
doi:10.1371/journal.pgen.0020193.t002
Table 3. Comparison of Results Obtained with First and Second
Site MOs
Phenotype Observed
with First MO
Phenotype Observed
with Second MO
n
þþ34
a
þ —1 4
— þ 5
—— 7
aIn 21 of these cases the observed phenotype was the same or similar to that obtained
with the first MO.
doi:10.1371/journal.pgen.0020193.t003
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Morpholino Screen in X. tropicalisTable 4. Phenotypic Classes and Synphenotype Groups Identified in This Study
Phenotypic
Class
Synphenotype
Group
Alternative
Group
Wellcome
Clone
Identifier
Gene Name Accession
Number
Representation in
Egg/Gas/Neu
cDNA Libraries
1. Gastrula 1. Gastrula defects TGas061b15 cD1LIC CT030328.1 0.4/0.5/0.7
TNeu143c03 Dp71.2 CR848277.2 1.1/0.5/0.9
TNeu073g23 E-Cad AL779506.2 4.3/7.2/5.4
TGas142e24 HMG20b CR761881.2 0.2/0.9/0.9
TEgg130i17 HP1beta CR760924.2 2.2/0.6/0.9
TGas055a16 Novel CR761559.2 0.0/0.6/0.0
TEgg040a13 Novel Zn finger CR762039.2 5.0/6.6/9.5
TEgg137c14 Suv39h1 AL877771.2 1.5/0.4/0.0
TGas012b13 Wnt5b CR760740.2 0.0/0.7/0.2
2. Short axis 2.1 Involution
defects
TNeu036f01 cD2HC.2 AL661523.2 —
TNeu087g20 Frizzled8.2 AL805138.2 0.0/0.4/1.1
TEgg003f20 Novel.2 CR848500.2 3.0/1.0/0.6
TGas124h10 Xnr1.2 CR761456.2 0.0/0.1/0.0
2.2 Gastrula or
neurula defects
TEgg065g11 Anillin AL860870.2 0.9/0.1/0.4
TEgg140p11 Novel CR761019.2 0.9/0.1/0.6
TGas080g08 Novel CR848087.2 0.0/0.4/0.0
TNeu097d01 Novel AL801792.2 0.0/0.1/0.2
TNeu127e06 PAR6B CR760394.2 0.0/0.6/0.2
TEgg126n13 Rad51 CR761167.2 0.7/0.6/0.2
TEgg104h10 Rb1 AL863992.2 0.7/1.3/0.4
TNeu052c18 Smad4a AL673301.2 0.0/0.5/0.6
TTpA012g23 Tbx3.2 BX703861.1 0.0/0.1/0.6
2.3 Short axis
surviving to tailbud
TTpA010k20 14-3-3beta CR760847.2 3.3/4.8/10.2
TTpA018g17 14-3-3epsilon CR848241.2 2.2/4.0/7.6
TGas138o08 14-3-3eta CR848634.2 0.0/0.5/2.0
TGas138o08 14-3-3eta.2 CR848634.2 0.0/0.5/2.0
TTpA008p09 14-3-3theta CT025504.2 3.5/6.3/10.4
TTpA008p09 14-3-3theta.2 CT025504.2 3.5/6.3/10.4
TNeu074i11 ARP2/3 1a CR926215.2 11.5/26.5/17.1
TEgg076c16 Delangin.2 AL865073.2 0.9/0.8/0.4
TGas086e13 Dp427p1 AL960406.2 —
TNeu143c03 Dp71 CR848277.2 1.1/0.5/0.9
TEgg139n15 DTC50; Dynactin 2 CR760618.2 0.4/0.3/0.2
TEgg033o10 Exostosin1 AL873459.2 3.0/0.9/0.4
TNeu054b08 Fbxl11 AL678939.2 0.0/0.0/0.4
TNeu087g20 Frizzled8 AL805138.2 0.0/0.4/1.1
TEgg017g13 Novel.2 CR848520.1 0.7/0.1/0.2
TGas066o14 Novel CR926381.2 —
TGas128o11 Novel CR762195.2 0.0/0.4/0.0
TNeu095k24 Smad7 CX822076.1 0.0/0.4/0.4
2.4 Short axis
surviving to tadpole
TNeu142f12 ActivinbetaB.2 AL803838.2 0.0/0.0/0.2
TNeu103f06 AHNAK CR760312.2 0.0/0.9/0.4
2.5 TEgg020c18 Chimerin 1 CT030309.1 1.5/0.0/0.0
TEgg018e06 Dlgh1 CR942446.2 1.1/0.1/0.0
TGas086e13 Dp427p1.2 AL960406.2 —
TGas087l14 Frizzled6 AL959523.2 0.2/0.1/0.0
TNeu065e03 Frizzled7 CR759995.1 1.1/0.5/0.6
TGas034n12 Fullback; NRH1 AL654321.1 0.0/2.0/3.3
TGas087m13 ING5 CT030479.1 1.3/1.9/0.7
2.5 TEgg135f07 Integrinbeta1 CT485679.1 5.9/3.7/4.1
TGas028k15 Lim1 CX494294.2 —
TEgg019e13 Novel CR761216.2 1.7/0.5/0.7
TEgg140p11 Novel.2 CR761019.2 0.9/0.1/0.6
TGas076l13 Novel AL959005.2 0.0/0.4/0.2
TGas083e14 Novel AL681066.2 2.8/2.0/0.6
TGas096p02 Novel CR761683.2 0.0/0.6/0.4
TNeu018d13 Novel AL638307.2 0.2/1.2/1.9
6.4 TNeu122d11 Novel CT030602.1 0.0/2.1/2.6
TEgg056i10 Novel; 67-11-3 CR761068.2 0.7/1.4/0.9
TGas010f07 Novel; Tsp101 CR848169.2 0.2/0.9/0.4
TGas098h07 Novel Zn finger CR762202.2 5.0/9.4/10.8
TGas106k21 Novel Zn finger AL629390.2 0.0/0.3/0.0
TGas136i03 p32INGL CR761858.2 4.3/1.3/1.3
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Phenotypic
Class
Synphenotype
Group
Alternative
Group
Wellcome
Clone
Identifier
Gene Name Accession
Number
Representation
inEgg/Gas/Neu
cDNA Libraries
TNeu034a23 p53 AL656057.1 0.9/2.6/2.4
2.5 TEgg133h21 Padi2 CX845163.1 0.2/0.2/0.0
TGas097o15 PKClambda; 14-3-3zeta CR848145.2 0.7/1.5/0.2
TGas008e09 Rb2; p130 AL630010.2 0.0/0.2/0.0
6.1 TNeu050m05 Smad3 CX891579.1 0.0/0.0/0.2
TEgg055l20 Suv39h2 AL958755.2 2.2/0.5/0.2
TNeu117j03 Tbx2 AL791963.2 0.0/0.2/1.1
TNeu117j03 Tbx2.2 AL791963.2 0.0/0.2/1.1
TGas124n10 Tbx6 CR942588.2 0.2/1.3/3.3
TNeu139i18 TCTEX1 AL781811.2 0.9/0.6/1.3
TNeu131c18 TGIF2 AL792964.2 0.2/0.7/0.4
TEgg012b23 TIEG2 CT030382.1 2.0/0.5/1.3
TGas116l23 Xbra CR761440.2 0.0/4.1/1.9
TGas116l23 Xbra.2 CR761440.2 0.0/4.1/1.9
TNeu061i04 Xbra3 CR760217.2 0.0/1.0/0.6
TGas097d22 Xnr3.2 AL971028.2 0.0/0.3/0.0
2.5 Normal body, short tail TGas049g17 Blimp1 AL649398.2 0.0/0.1/0.2
TNeu087f10 Cdx2; CAD2 CR760338.2 0.0/0.2/0.6
TNeu123l16 Mu2 AL802310.2 0.2/4.4/5.0
TGas144p20 Wnt11 CT025383.1 0.2/0.5/0.4
2.6 Proportionately small TGas029e03 Cdc42 BX727142.1 6.1/7.7/7.2
6.4 TGas076c07 Novel CT030100.2 0.0/0.2/0.0
TNeu123g11 Novel CR761938.2 0.0/0.6/0.9
TNeu072l04 RBBP1.2 CR848405.2 0.4/0.2/0.6
3. Late degradation 3. Degradation after tailbud TGas053l04 CPSF4 CR761660.2 2.0/1.2/0.9
4. Curved body axis 4. Curved body axis TTpA018g17 14-3-3epsilon.2 CR848241.2 2.2/4.0/7.6
TEgg077g12 ARP6 CR760917.1 2.2/0.3/0.4
TGas050a15 cD2LC CR761866.2 1.1/1.3/3.0
5. Ventral defect 5.1 normal length, ventral oedema TNeu142f12 ActivinbetaB AL803838.2 0.0/0.0/0.2
TNeu069m07 Anf-1 CR760108.2 0.0/0.1/0.2
TNeu045c17 BMP4 CR761955.1 0.0/1.7/1.1
TEgg021o06 Smad1 AL855227.2 4.8/3.9/1.3
5.2 Normal length, ventral reduction TNeu118d19 Wnt8 CR760475.2 0.0/2.6/0.7
6. Bent axis 6.1 Short body, up-turned tail,
and dorsalized
2.4 TEgg076c16 Delangin AL865073.2 0.9/0.8/0.4
2.4 TGas128m18 Flamingo1.2 EF012769.1 —
TNeu059i07 Frizzled2 AL677424.2 1.7/1.2/1.1
2.4 TGas077n04 Novel CR760737.2 0.0/1.0/0.0
2.4 TNeu089n21 Novel CR761967.2 0.4/0.0/0.4
2.4 TNeu072l04 RBBP1 CR848405.2 0.4/0.2/0.6
2.4, 5.1, 7.1 TEgg068f10 REEP4.2 CR926301.2 2.2/0.3/0.0
2.4 TGas073h08 Smad6 AL784104.2 —
2.4 TTpA011k01 Suv420h1; SET8 CR760868.2 1.3/0.4/0.4
2.4 TGas124n10 Tbx6.2 CR942588.2 0.2/1.3/3.3
6.2 Short body, up-turned tail,
and ventralized
6.3 CX843311 BS69.2 CX843311.2 —
2.4 TGas124j21 MARK2; Par1 BQ389144.1 0.2/0.8/1.3
2.4 TEgg003f20 Novel CR848500.2 3.0/1.0/0.6
2.4 TEgg048b09 VegT.2 CR760687.2 5.7/8.5/1.3
6.3 Normal body length, wavy tail 2.4 TNeu036f01 cD2HC AL661523.2 —
TEgg096l10 cD2IC.2 CT030381.1 1.1/1.6/0.6
TGas128i12 Dach2l AL959426.2 0.0/0.2/0.0
TEgg061a19 FGFR4 AL630886.2 1.7/1.8/1.1
TEgg061a19 FGFR4.2 AL630886.2 1.7/1.8/1.1
TNeu065e03 Frizzled7.2 CR759995.1 1.1/0.5/0.6
TGas131h15 Hox-7.1; Msx1 CR855795.2 0.0/2.4/2.8
TTbA033a09 Mu1b CF224028.1 0.0/0.0/0.0
TEgg017g13 Novel CR848520.1 0.7/0.1/0.2
TGas055a16 Novel.2 CR761559.2 0.0/0.6/0.0
2.4 TGas128o11 Novel.2 CR762195.2 0.0/0.4/0.0
TNeu109g23 Novel AL875318.2 2.2/0.1/0.4
TEgg118f13 Smad2 AL867605.2 2.6/0.5/0.9
TTpA007k16 Smad5/8a CX909167.1 0.4/0.0/0.0
TTpA012g23 Tbx3 BX703861.1 0.0/0.1/0.6
TNeu139i18 TCTEX1.2 AL781811.2 0.9/0.6/1.3
TNeu055p01 TGIF1 CR848339.2 0.2/0.5/1.9
6.4 Bent-up tail or arched back 2.5 TGas030a23 aD1LC AL646908.2 0.2/0.9/0.6
2.4 TGas061b15 cD1LIC.2 CT030328.1 0.4/0.5/0.7
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Morpholino Screen in X. tropicalisTable 4 also provides an insight into the temporal
expression pattern of each gene, by indicating how frequently
its transcripts are represented in cDNA libraries derived from
egg, gastrula, and neurula cDNA libraries [24]. This is of
interest because it is possible that the products of maternally
expressed genes are more difﬁcult to deplete than are newly
expressed zygotic transcripts [29]. Our analysis, however,
reveals no clear relationship between the maternal levels of
expression of a gene and the likelihood of an MO directed
against that gene producing a phenotype (unpublished data).
The Phenotypic Classes
Gastrula defects. The members of this class, targeted by
nine MOs, exhibit defects during gastrula stages and all die
before the mid-neurula stage (Figure 4). The phenotypes
falling into this class are very similar, allowing the genes to be
classed as a single synphenotype group. The speciﬁcities of
the MOs that cause these defects are examined in the next
section of this paper, and we are currently investigating
whether the observed phenotype derives, for example, from
defects in germ layer speciﬁcation or in the cell cycle.
Shortened axes. This class comprises 71 genes (targeted
using a total of 78 MOs) whose loss-of-function phenotypes
are characterized by a shortening of the anterior-posterior
body axis (Figures 5–7). These genes have been divided into
six synphenotype groups, including: (i) involution defects
(four MOs); (ii) gastrula/neurula defects (nine MOs); (iii) short
Table 4. continued
Phenotypic
Class
Synphenotype
Group
Alternative
Group
Wellcome
Clone
Identifier
Gene Name Accession
Number
Representation
inEgg/Gas/Neu
cDNA Libraries
2.4 TGas020f13 DNALC4 CR762240.2 1.3/1.2/1.1
2.4 TGas028g07 DOC-1 AL652680.2 0.4/0.2/0.2
2.4 TGas047c23 EED CR848605.2 4.8/1.2/1.3
2.4 TGas092f08 FGFR3; CEK2 AL964086.2 0.0/0.1/0.2
2.4 TGas092f08 FGFR3.2; CEK2.2 AL964086.2 0.0/0.1/0.2
2.4 TEgg061a13 Novel CR761145.2 0.7/0.0/0.0
2.4 TEgg078i21 Novel.2 AL878749.2 0.2/0.0/0.0
2.4 TEgg098o12 Novel AL865292.2 0.4/0.0/0.0
2.4 TNeu062k05 Novel CR848314.2 1.1/0.1/0.4
2.4 TNeu104f22 Novel AL660492.2 0.0/0.6/0.9
2.4 TGas076f10 Novel; NOP 7 associated 1 CR761697.2 0.0/0.4/0.4
2.4 TGas143j10 Novel Zn finger CR848612.2 2.4/1.7/0.7
2.4 TEgg004p11 Par3B AL849138.2 0.7/0.2/0.0
2.4 TGas080l23 RxRbeta CR926364.2 0.4/1.7/1.3
2.4 TTpA011h07 Serpina1 BX704113.1 0.0/0.0/0.0
2.4 TEgg110h11 ST13; novel CR942468.2 0.2/0.8/0.0
2.4 TGas097d22 Xnr3 AL971028.2 0.0/0.3/0.0
6.5 Bent-down tail TTpA010k20 14-3-3beta.2 CR760847.2 3.3/4.8/10.2
TGas058k09 CPSF2 AL681922.2 0.0/1.2/0.7
TNeu132f09 EDIL3 AL785940.2 0.9/0.4/0.9
2.4 TGas031a08 Lefty-b AL649862.2 0.0/0.4/0.0
TEgg078i21 Novel AL878749.2 0.2/0.0/0.0
TGas083e14 Novel.2 AL681066.2 2.8/2.0/0.6
TGas141c24 Novel CR761833.2 0.0/1.2/0.2
TNeu053k08 Novel.2 CR760048.2 0.0/0.0/0.2
TNeu062k05 Novel.2 CR848314.2 1.1/0.1/0.4
TGas106k21 Novel Zn finger.2 AL629390.2 0.0/0.3/0.0
6.2 TNeu123j18 PAR6A CR855473.2 2.8/0.4/0.6
6.2 TEgg032k01 Smad10 CT025227.1 1.1/0.3/0.2
2.4 TGas012b13 Wnt5b.2 CR760740.2 0.0/0.7/0.2
7. Motility defects 7.1 Mildly kinked tail and motility defects TEgg066c16 CC1 CR761074.2 0.9/0.1/0.0
TNeu136h04 HMG17 CR761935.2 8.3/10.2/20.3
TNeu108m10 HoxC8 CR926189.2 0.0/0.0/0.6
TEgg068f10 REEP4 CR926301.2 2.2/0.3/0.0
TGas064l01 Tinp1 CR848589.2 0.7/2.0/2.4
TEgg131f10 VHLH CR761285.2 0.2/0.2/0.0
7.2 Swimming in circles TEgg021k02 Aurora A CR760668.2 16.7/1.2/1.5
TNeu102i09 FrzA CR926172.2 0.0/0.0/0.6
TNeu104l10 Mu1a CR760351.2 0.0/1.2/0.7
7.3 Normal appearance but paralyzed TNeu102i09 FrzA.2 CR926172.2 0.0/0.0/0.6
TNeu053k08 Novel CR760048.2 0.0/0.0/0.2
TNeu098a04 Novel CR760171.2 0.0/0.4/0.6
TEgg043a17 Novel Zn finger CR926298.2 3.9/1.8/2.6
TEgg058h11 Novel Zn finger CR761015.2 3.0/1.3/0.9
The third column in the Table indicates cases where a phenotype might be assigned to an alternative synphenotype group. In the fifth column the suffix ‘‘.2’’ indicates that the data
pertain to the use of a second site antisense MO. The final column in the Table indicates the frequency with which each transcript is represented in the Egg, Gastrula, and Neurula cDNA
libraries described by Gilchrist and colleagues [24], represented as a percentage multiplied by 100. The numbers of sequenced clones in each library are: Egg: 45,948; Gastrula: 112,307;
Neurula: 53,822.
doi:10.1371/journal.pgen.0020193.t004
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Morpholino Screen in X. tropicalisaxis with death occurring after tailbud stages (18 MOs); (iv)
short axis surviving to tadpole stages (39 MOs); (v) normal
body length with short tail (four MOs); and (vi) proportion-
ately small (four MOs). The observed phenotypes may derive
from (among other things) defects in germ layer speciﬁcation,
organizer function, DNA damage, or cell death.
Late degradation. This class contains only one member:
CPSF4. Loss-of-function individuals develop normally until
the tailbud stage, after which time they begin to disintegrate
(Figure 8). This is a more severe phenotype than that
observed for zebraﬁsh CPSF4, in which null mutants are
characterized by a lack of brachial arches [30]. There may be
different requirements for the gene in the two species, or
perhaps there is some functional redundancy in zebraﬁsh that
derives from its partially duplicated genome [9].
Curved body axis. Loss-of-function of the three genes in
this class causes the body axes of embryos to curve either to
the left or the right (Figure 9). This phenotype may derive
from defects in notochord or somites, or in laterality.
Ventral tissue defects. This class contains ﬁve genes whose
loss-of-function phenotypes are characterized by defects in
ventral tissues (Figure 10). Its members can be divided into
two synphenotype groups, those with ventral oedema at the
tadpole stage (n ¼ 4) and those with a reduction in ventral
tissue (n ¼ 1). The former group may exhibit defects in heart
or kidney development, or osmoregulation; the latter may
show defects in ventral patterning.
Figure 3. The Phenotypic Classes and Synphenotype Groups Defined by This Work
doi:10.1371/journal.pgen.0020193.g003
Figure 4. The Nine Members of the Gastrula Defect Phenotypic Class
Note that the blastopore in control embryos is closing normally, but is either absent or severely delayed in embryos in which the functions of the
indicated genes are inhibited. All embryos shown are at gastrula stage 10.5 to 11.5. In this figure and in Figures 5–13, the number in the top left hand
side of each panel represents the synphenotype group to which the embryos belong, and the name of the gene in question is shown bottom left.
doi:10.1371/journal.pgen.0020193.g004
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Morpholino Screen in X. tropicalisBent axis. The 61 genes in this class (targeted by 63 MOs)
can be divided into ﬁve synphenotype groups, all of which are
characterized by a bent antero-posterior body axis (Figures
11 and 12). The groups are (i) short dorsalized body with
upturned tail (ten MOs); (ii) short ventralized body with
upturned tail (four MOs); (iii) normal body and wavy tail (17
MOs); (iv) arched back with bent-up tail (19 MOs); and (v)
bent-down tail (13 MOs). All these phenotypes are likely to
derive from defects in neural tube, somites, or notochord.
Motility defects. This class comprises genes whose loss-of-
function causes embryos to develop apparently normally (or
perhaps with slight defects in tail development) but whose
motility is abnormal, greatly reduced, or absent (Figure 13).
The 14 genes in this class can be divided into three
synphenotype groups: (i) mildly kinked tail with greatly
reduced motility (six MOs); (ii) embryos swim in circles (three
MOs); and (iii) embryos are paralyzed and cannot swim even
when prodded with a pair of forceps (ﬁve MOs). In all these
Figure 5. The First 32 Members of the Shortened Axis Phenotypic Class
This class can be subdivided into six synphenotype groups, as indicated in Figure 3 and Table 4. Members of the first three synphenotype groups
(involution defects, gastrula or neurula defects, and short axis surviving to tailbud) are shown at tailbud stage (stage 24–28), while the member of the
second synphenotype group shown here (short axis surviving to tadpole) is shown at tadpole stage 35–41. Lines in this and subsequent figures
demarcate the different synexpression groups.
doi:10.1371/journal.pgen.0020193.g005
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Morpholino Screen in X. tropicaliscases, embryonic heartbeat was normal. Effects are likely to
derive from defects in muscle or the nervous system, although
those that swim in circles may exhibit defects in balance or
laterality. This is under investigation.
Specificity Revisited: Apoptosis
As discussed above, interpretation of the experiments
described in this paper, and indeed of all experiments making
use of MOs, requires that the effects of the MOs are speciﬁc.
Several criteria for speciﬁcity are described above, and these
lead us to conclude that the effects of the MOs are usually
speciﬁc. To investigate this important issue in more detail, we
ﬁrst asked if the possible non-speciﬁc effects of MOs might
includetheinductionofapoptoticcelldeath.Apoptosismight,
inparticular,underlielaterphenotypessuchasthoseexhibited
in the ‘‘short axis surviving to tadpole’’ synphenotype group.
To address this possibility we examined embryos from
several synphenotype groups using TUNEL staining [31]. Our
results (Figure 14) indicate that the Gene Tools standard
Figure 6. The Second 32 Members of the Shortened Axis Phenotypic Class
This class can be subdivided into six synphenotype groups, as indicated in Figure 3 and Table 4. The figure shows examples of the fourth synphenotype
group (short axis surviving to tadpole) at tadpole stages 35–41.
doi:10.1371/journal.pgen.0020193.g006
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Morpholino Screen in X. tropicaliscontrol MO does not cause an increase in apoptosis at any
stage. MOs directed against BMP4, Flamingo1, Frizzled2, Hox7.1,
ING5, p32INGL, Smad1, and Tbx6 do not cause signiﬁcant
changes in levels of apoptosis at tailbud stages, even though
the MOs in question have usually induced a phenotype by this
time. Although MOs directed against Xbra, Xbra3, Xnr3, and
Tbx3 do cause a signiﬁcant increase in apoptosis by tailbud
stages, we note that both Xbra and Tbx3 have previously been
implicated in programmed cell death [32–34], although the
role of Xnr3 in apoptosis remains to be resolved.
Together, these results suggest that the phenotypes we
observe do not derive from non-speciﬁc apoptotic cell death.
Specificity Revisited: The Gastrula Defects
As a ﬁnal attempt to investigate the question of the
speciﬁcity of MOs, we decided to concentrate speciﬁcally on
the class of gastrula defects, and to ask, for each member of
t h ec l a s s ,w h e t h e ras e c o n ds i t eM Oy i e l d st h es a m e
phenotype, whether an MO with ﬁve altered bases causes a
phenotype, and whether the phenotype can be rescued by
expression of a form of the target mRNA that lacks sequence
complementary to the MO in question. The results of these
experiments are shown in Figure 15 and Table 5. They
indicate that for all nine MOs that cause gastrula defects,
alteration of ﬁve bases causes no phenotype to occur in
injected embryos, while ﬁve of the nine MOs prove to exert
speciﬁc effects in the sense that the phenotype can be rescued
by injection of the cognate mRNA. As discussed above, the
latter is a particularly strict test and will underestimate the
degree of speciﬁcity quite signiﬁcantly.
It was possible to rescue the effects of six out of eight of the
second site MOs, indicating that their effects too are speciﬁc.
However, the second site MOs almost invariably yielded a less
severe phenotype than did the corresponding ﬁrst site MOs.
This observation is consistent with the results described
above (Figure 2 and Table 3), and with the fact that it is the
ﬁrst site MOs that are designed to be the optimum antisense
oligonucleotide for the mRNA in question (see Discussion).
Signiﬁcantly, a less severe phenotype was also observed
using second site MOs in a series of experiments investigating
the expression of genes such as Chordin, Xbra, Wnt11, Wnt8,
Sox17, and E-Cadherin (unpublished data). In these experi-
ments, injection of an MO with ﬁve altered bases caused little
alteration in gene expression, while ﬁrst site MOs directed
against, for example, Dp71, HP1beta, and TEgg040a13 caused
signiﬁcant down-regulation of mesodermally expressed genes
such as Chordin, Xbra, and Wnt11. Second site MOs caused
much less dramatic down-regulation in the cases of HP1beta
and TEgg040a13, consistent with their lack of effect on
development (Figure 15), but the second site MO directed
Figure 7. The Final 14 Members of the Shortened Axis Phenotypic Class
This class can be subdivided into six synphenotype groups, as indicated in Figure 3 and Table 4. The figure shows examples of the second three
synphenotype groups (short axis surviving to tadpole, normal body short tail, and proportionately small) at tadpole stages 35–41.
doi:10.1371/journal.pgen.0020193.g007
Figure 8. CPSF4, the Sole Member of the Late Degradation Phenotypic
Class
Embryos injected with MOs targeting this gene appear perfectly normal
to early tailbud stage 30 but then rapidly disintegrate. Embryos are
shown at the tailbud stage (stage 24–28).
doi:10.1371/journal.pgen.0020193.g008
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Morpholino Screen in X. tropicalisagainst Dp71, which disrupted gastrulation, also interfered
with mesodermal gene expression.
Synphenotype and Synexpression Groups
Genes within a synphenotype group do not necessarily
belong to the same synexpression group [20]. This may be
illustrated by referring to two synphenotype groups within
the class of genes required for normal motility. Thus, of the
three genes whose loss-of-activity causes embryos to swim in
circles, one (AuroraA) is expressed at highest levels in the head
(Figure 16A), another (FrzA) is expressed most strongly in
muscle, heart, pronephros, and otic vesicle (Figure 16B), and
the third (Mu1a) is expressed in the brain and neural tube but
absent from muscle (Figure 16C). Similarly, of the genes
whose loss-of-function causes paralysis, one (TEgg043a17) is
expressed almost ubiquitously (Figure 16D), another
(TNeu053K08) is highly expressed in muscle (Figure 16E),
and yet another (TNeu098a04) is most strongly expressed in
the posterior neural tube (Figure 16F). These observations are
discussed below.
Web Access
The results described in this paper can be accessed through
a database at http://rd.plos.org/pgen_0057_0001_
Xenopus_morpholino_screen. For each gene we have
provided (i) the Sanger Institute clone identiﬁer; (ii) the
accepted gene name, where available; (iii) MO sequence(s); (iv)
phenotypic class and synphenotype group; (v) a description of
the phenotype; (vi) images of the phenotype; (vii) images of
the expression pattern of the targeted gene; and (viii) the
temporal expression proﬁles of the genes derived from their
representation in X. tropicalis cDNA libraries.
Discussion
In this paper we use MOs to investigate by reverse genetics
the functions of 202 genes in X. tropicalis. We have assessed the
speciﬁcities of 60 of the MOs by injecting a second antisense
oligonucleotide, compared the functions of the X. tropicalis
genes with those of their orthologs in other species (including
the mouse), and divided the genes, based on their loss-of-
function phenotypes, into seven phenotypic classes and 19
synphenotype groups. As we discuss below, it is possible that
members of the same synphenotype group are involved in the
same developmental pathway. We have also tested in some
detail the speciﬁcities of the MOs that cause defects to occur
during gastrulation. Together, our results suggest that a large-
scale attempt to inhibit the functions of all genes expressed
during gastrula stages of X. tropicalis is feasible and that it
should shed light on gene function in other organisms.
Specificity of MOs
Meaningful interpretation of the results presented in this
paper requires that our MOs are non-toxic and act in a
speciﬁc manner. First, as described above, our experiments
indicate that injection of antisense MOs does not cause non-
speciﬁc phenotypes to form, and there is no evidence for
non-speciﬁc apoptotic programmed cell death in the embryo
(Figure 14).
We have addressed the question of speciﬁcity by designing
additional, non-overlapping MOs against 60 of the mRNAs
targeted in this screen. For the 48 genes where the ﬁrst MO
yielded a phenotype (at a dose of 10–15 ng), the second site
MO perturbed development in 34 of the cases, and in 21 of
these the phenotype was the same or similar (Figure 2 and
Table 3). In the remaining 13 cases, our analysis of the
Figure 9. The Three Members of the Curved Body Axis Phenotypic Class
Embryos are shown at the tadpole stage (stage 35–41).
doi:10.1371/journal.pgen.0020193.g009
Figure 10. The Five Members of the Ventral Defects Phenotypic Class
This class can be subdivided into two synphenotype groups, as indicated in Figure 3 and Table 4. All embryos are shown at the tadpole stage (stage 35–
41).
doi:10.1371/journal.pgen.0020193.g010
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Morpholino Screen in X. tropicalisgastrula class of defects (Figure 15 and Table 5) suggests that
the disruption of development observed using the second site
MO might represent a weaker manifestation of that caused by
the ﬁrst MO.
There were 14 cases in which the ﬁrst MOs yielded a
phenotype but the second MOs did not. In these examples, we
suspect that the results obtained with the ﬁrst site MOs are
the more reliable. These were designed as the optimal MOs
for the mRNAs in question (see Materials and Methods), and
as discussed above, it is likely that the second MOs, designed
to be non-overlapping with the ﬁrst while being targeted to a
similar region of the mRNA, are less effective, perhaps
because of RNA secondary structure (see also Figure 15 and
Table 5). In support of this idea, we note that in three of the
ﬁve cases where the gene had been studied previously, the
ﬁrst MO phenotypes resembled those obtained by other
means in Xenopus or in other vertebrates. These include Frz2,
Wnt8, and Wnt11 (Table 3).
Our experiments investigating the speciﬁcities of the nine
MOs that cause defects in gastrulation (Table 5 and Figure 15)
Figure 11. The First 32 Members of the Bent Axis Phenotypic Class
This class can be subdivided into five synphenotype groups, as indicated in Figure 3 and Table 4. All embryos are shown at the tadpole stage (stage 35–
41).
doi:10.1371/journal.pgen.0020193.g011
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effects, because oligonucleotides that differ in ﬁve nucleo-
tides from their target sequences have no effect, and the
effects of the speciﬁc MOs can frequently be rescued by
injection of the cognate mRNA. We also observe that the
effects of our ﬁrst site MOs are usually stronger than those of
the second site MOs, as noted above.
Of the 12 genes for which the ﬁrst MO yielded no
phenotype, the second MO did cause abnormal development
in ﬁve cases. Of all the phenotypes observed in this study,
these, representing just 2% of the total, are perhaps the most
likely to be caused by non-speciﬁc effects, because the second
site MOs may be less effective than the ﬁrst site MOs in
targeting the desired gene product. However, we again note
that three of these ﬁve genes (Flamingo1, nodal-related 1, and
VegT) have been investigated previously in Xenopus or in other
vertebrates and that the loss-of-function phenotypes in all
three cases resemble those obtained in this study. We suspect,
therefore, that the speciﬁcity of MOs is, in general, high, and
the absence of a phenotype may reﬂect the complexity of
Figure 12. The Final 31 Members of the Bent Axis Phenotypic Class
This class can be subdivided into five synphenotype groups, as indicated in Figure 3 and Table 4. All embryos are shown at the tadpole stage (stage 35–
41).
doi:10.1371/journal.pgen.0020193.g012
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provide valuable information about gene function in the
early embryo of X. tropicalis and will be able to inform future
analyses of gene function in other vertebrate embryos.
Comparison with Other Functional Screens
How does the screen described in this paper compare with
others carried out in Xenopus and in other species? The most
obvious comparison is with a smaller scale X. tropicalis MO
screen carried out by Kenwrick and colleagues [18]. These
authors targeted 26 genes expressed in the neural plate and
neural tube of X. tropicalis, and like us required that greater
than 50% of injected embryos should develop abnormally for
a particular MO to be classiﬁed as causing a phenotype. This
more limited study reported a lower frequency of loss-of-
function phenotypes (23%) than that reported here (62%–
67%). However, we note that Kenwrick and colleagues [18]
allowed their embryos to develop only to stage 30 and used a
dose of MO corresponding to our lower concentration. If we
apply the same restrictions to our own larger dataset, using
only the ﬁrst site MOs, we observe loss-of-function pheno-
types in 48% of cases (97 out of 202), a ﬁgure that is closer to
that of Kenwrick et al. [18] and which indicates that many of
the phenotypes we observe are detectable only after the
tailbud stage. We also note that if we include in this analysis
only the 68 novel genes, our frequency of loss-of-function
phenotypes falls to just 38% (see Table 1).
MOs have also been used to study gene function in the
ascidian Ciona intestinalis [6]. Loss-of-function of 40 of the 200
genes tested in these experiments caused embryos to develop
abnormally in  50% of cases, and of these genes many had
counterparts in mouse and human embryos. At 20%, the
frequency of loss-of-function phenotypes in Ciona is again
lower than that observed in this paper with X. tropicalis,
although a higher frequency might have been observed if
embryos had been allowed to develop for longer or if a higher
dose of MO had been used.
Other large-scale screens have been performed in C. elegans
and D. melanogaster. In C. elegans, genome-wide RNAi screens
have revealed early embryonic mutant phenotypes in 9% of
the genes studied [2,3]; as in our own experiments, it is likely
that additional phenotypes would become apparent at later
stages of development. In Drosophila, RNAi screens have been
used to search for novel components of signaling pathways
such as the JAK/STAT and Wnt pathways [4,5,35]. These
targeted screens inevitably yield fewer phenotypes, but they
are very effective in identifying regulators of the signaling
pathways in question. A similar targeted screen has also been
carried out in the zebraﬁsh, where MOs have been used to
study the functions of the homologs of genes expressed in
human haematopoietic stem cells. In these experiments, 23%
(14/61) of the MOs caused haematopoietic defects in the
developing embryos [8].
It is difﬁcult to make comparisons with the frequencies of
embryonic phenotypes obtained in mouse embryos, because
the mouse data frequently refer to embryonic lethal
phenotypes (and many of our milder X. tropicalis phenotypes
may not be lethal), and because mutants in which a
phenotype is not observed, or which have only a mild
postnatal phenotype, are less likely to be published. We note,
however, that one study has used a modiﬁed gene-trap
approach to analyze the functions of 60 genes encoding
secreted and membrane proteins and that loss-of-function of
one third of these causes embryonic and postnatal death [36].
Another gene-trap study, which more resembles ours in the
sense that gene selection was more random, observed
Figure 13. The 14 Members of the Motility Defects Phenotypic Class
This class can be subdivided into three synphenotype groups, as indicated in Figure 3 and Table 4. All embryos are shown at the tadpole stage (stage
35–41).
doi:10.1371/journal.pgen.0020193.g013
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resembles the 66% observed in the present work.
Comparisons with Loss-of-Function Phenotypes in
Different Species
To ask whether the loss-of-function phenotypes we observe
in X. tropicalis might allow us to predict gene function in other
species (including mammals), we compared our results with
those obtained by the removal of the orthologous gene in
other vertebrate species, including the zebraﬁsh and the
mouse.
Some of the genes studied here have also been investigated
in X. laevis, usually by dominant-negative approaches. These
include Xbra [38], the FGF receptor [39,40], Frizzled8 [41],
Xwnt8 [42], and the BMP receptor [43–45]. In each case the
phenotype caused by our MOs in X. tropicalis resembles that
observed in X. laevis, although the X. tropicalis phenotype is
sometimes weaker. For example, the Xtbra MO does not
produce as severe a shortening of the antero-posterior axis as
does the dominant-interfering construct Xbra-En
R [38], and
the individual MOs targeted against different FGF receptors
do not yield phenotypes as dramatic as that caused by the
dominant-negative FGF receptor XFD [39,40]. In each case it
is likely that the dominant-negative construct is capable of
inhibiting the function of more than one gene product. For
example, Xbra-En
R is likely to inhibit the activities of all three
known Xbra genes in the X. laevis genome [46–48] while the
MOs directed against the X. tropicalis genes will target only
one of the two homologs we have identiﬁed in that species
(Table 4). That said, there are cases where the X. laevis and X.
tropicalis phenotypes are very similar. These include, for
example, loss-of-function of Frizzled 8, which in both species
causes shortening of the antero-posterior axis and defects in
neural tube closure [41].
Figure 14. Apoptosis Is Not a Non-Specific Response to Injection of MOs
Embryos were injected at the one-cell stage with 15 ng of the indicated MO and allowed to develop to the equivalent of the tailbud stage, when they
were examined by TUNEL staining. Note that only the Tbx3.2, Xnr3.2, and Xbra.2 MOs caused a level of apoptosis that exceeded the level observed in
control embryos (injected with 30 ng of the Gene Tools control MO).
doi:10.1371/journal.pgen.0020193.g014
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Morpholino Screen in X. tropicalisFigure 15. Tests of the Specificities of the Phenotypes Observed in the Gastrula Defects Phenotypic Class
The specificities of the MOs used to define this phenotypic class were investigated by injecting 10–15 ng of the Gene Tools standard control MO
(Column 1); the original antisense MO (Column 2); MO1 together with 1 ng of a form of the target RNA that lacks the MO target sequence (Column 3);
MO1 (or, in the case of Dp71, MO2) with five mismatched bases (Column 4); MO2 (Column 5); MO2 together with 1 ng of a form of the target RNA that
lacks the MO target sequence (Column 6).
The results of these experiments are summarized in Table 5. In Column 1 (control MO) embryos are shown at the mid-gastrula stage. Embryos in
Column 2 (MO1) are at the same stage as those in Column 1, but (with the exception of Dp71) gastrulation is delayed or inhibited. In the case of Dp71,
MO1 does not inhibit gastrulation but does cause embryos to develop with a shortened axis. Column 3 indicates that for five of the nine MOs studied,
complete or partial rescue of the phenotype was obtained by injection of the cognate RNA. In these experiments, embryos were allowed to develop
beyond gastrula stages to tailbud or tadpole stages. In the case of D1LIC, rescue was more complete at tailbud stages (upper panel) than tadpole stages
(lower panel). Column 4 shows that for each of the nine MOs, changing five bases caused them to lose the ability to disrupt development.
Use of a second site MO usually causes a milder phenotype than is observed with MO1 (Column 5), but the phenotype is usually specific, in the sense
that it can frequently be rescued by injection of the cognate RNA (Column 6).
MO1, original antisense oligonucleotide; MO2, second site MO.
doi:10.1371/journal.pgen.0020193.g015
PLoS Genetics | www.plosgenetics.org November 2006 | Volume 2 | Issue 11 | e193 1768
Morpholino Screen in X. tropicalisTo our knowledge, 57 of the genes analyzed in this paper
have been targeted in mouse embryos [49] (Table 6). For 29 of
these, the X. tropicalis phenotypes resemble those observed in
the equivalent mouse homozygous null mutant and in ﬁve
cases a phenotype is observed in neither species. For example,
loss of Rad51 function in both X. tropicalis and mouse causes a
disruption of gastrulation and neurulation [50] (Figure 5;
Tables 4 and 5), while another gene with a conserved
biological role proves to be Cdx2, which in X. tropicalis is
required for proper posterior development and tailbud
elongation (Figure 7; Tables 4 and 5). In this case, conven-
tional gene targeting in the mouse embryo does not reveal
this function because homozygous null Cdx2 mutant mice die
before implantation [51]. However, tetraploid aggregation
experiments show that the gene is also required later in
development, during gastrulation and tailbud elongation in a
role that resembles its function in frogs [52]. These
observations suggest that experiments in X. tropicalis can help
reveal the post-implantation functions of genes that cause
early lethality.
In nine cases, MOs elicited a different phenotype in X.
tropicalis and mouse, in eight cases a phenotype has been
recorded in the mouse, but was not observed in X. tropicalis in
this study, and for six genes a phenotype was observed in frog
but not in mouse. These differences may reﬂect different
developmental strategies in the two species, including the
deployment of different gene family members to accomplish
a speciﬁc developmental task, or, particularly for the last
group of six genes, functional redundancy in the mouse
embryo. The gene Fgfr4a illustrates this point. Two MOs
Figure 16. Members of the Same Synphenotype Group Do Not Necessarily Have the Same Expression Patterns
The six examples shown here are all from the motility defects class. (A–C) Expression patterns of the three members of the swimming in circles
synphenotype group. (D–F) Expression patterns of three members of the normal appearance but paralyzed synphenotype group. Members of each
group are not expressed in the same patterns and so do not belong to the same synexpression group (see text).
doi:10.1371/journal.pgen.0020193.g016
Table 5. Specificity Controls Applied to the Gastrulation Synphenotype Group
Wellcome
Clone
Identifier
Gene First MO Second MO
Synphenotype
Group
5-Base
Mismatch
Rescue
(28   n   32)
Synphenotype
Group
5-Base
Mismatch
Rescue
(28   n   33)
TGas061b15 D1LIC Gastrula 100% normal Complete: 90%
Partial: 0% None: 10%
Normal body,
wavy tail
ND Complete: 100%,
Partial: 0%, None: 0%
TNeu143c03 Dp71/40 Short axissurviving
to tailbud
ND Complete: 30%
Partial: 70% None: 0
Gastrula 100% normal Complete: 0%,
Partial: 100%, None: 0%
TNeu073g23 E-cadherin Gastrula 100% normal Complete: 0%
Partial: 0% None: 100%
Gastrula ND Complete: 0%,
Partial: 0%, None: 100%
TGas142e24 HMG20b Gastrula 100% normal Complete: 50%
Partial: 50% None: 0%
No phenotype ND Complete: 100%,
Partial: 0%, None: 0%
TEgg130i17 HP1beta Gastrula 100% normal Complete: 20%
Partial: 5% None: 75%
Bent-up tail ND Complete: 33%
Partial: 67% None: 0%
TEgg137c14 Suv(3–9)1 Gastrula 100% normal Complete: 0%
Partial: 0% None: 100%
Curved body ND Complete: 0%
Partial: 100% None: 0%
TEgg040a13 Novel Gastrula 100% normal Complete: 0%
Partial: 0% None: 100%
No phenotype ND N/A
TGas055a16 Novel Gastrula 100% normal Complete: 0%
Partial: 100% None: 0%
Normal body, wavy tail ND Complete: 0%
Partial: 75% None: 25%
TGas012b13 Wnt5b Gastrula 100% normal Complete: 0%
Partial: 0% None: 100%
Bent-down tail ND Complete: 0%
Partial: 0% None: 100%
ND, not determined.
doi:10.1371/journal.pgen.0020193.t005
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type in X. tropicalis, in which the body axis appeared normal
but the tail of the tadpole was ‘‘wavy.’’ No such phenotype has
been observed in the mouse embryo [53], although the gene is
required for muscle regeneration in this species [54].
However, we note that mutations in the related gene Fgfr1
cause abnormal mesodermal patterning in the mouse
embryo, with loss of somites and expansion of axial
mesoderm at the expense of paraxial tissues [55].
There are also similarities between the phenotypes we
observe in X. tropicalis and those obtained in the zebraﬁsh
(Table 7). Of the 20 genes for which data are available for
both species [56], 12 phenotypes appear to be similar and in
ﬁve cases a phenotype was observed in neither species. The
remaining three differences between X. tropicalis and the
zebraﬁsh may derive from differences in biology, a failure to
obtain null mutations in zebraﬁsh, a failure of the X. tropicalis
MO to inhibit the gene in question, or the whole genome
duplication that occurred in zebraﬁsh [9,10].
Together, the similarities between the phenotypes observed
in X. tropicalis and those obtained in other species argues that
work in X. tropicalis should shed light on general vertebrate
developmental mechanisms.
Synphenotype Groups and Developmental Pathways
Genetic screens in organisms such as D. melanogaster and the
zebraﬁsh Danio rerio allow one to identify genes that function
in the same developmental pathway [57], and the same is
likely to be true of genes that are members of the same
synphenotype groups that are deﬁned in this study. This
possibility is illustrated by synphenotype group 6.1 (Short
body, upturned tail, dorsalized), which includes the genes
SET8, delangin, ﬂamingo1.2, frizzled2, RBBP1, TBX6.2, Smad6,
and three novel genes. The protein encoded by the ﬁrst of
these genes, SET8, functions as a Histone 4–lysine 20 (H4–
K20) methyltransferase. Targeting of this enzyme to hetero-
chromatic regions requires Suv39h1 [58], which itself inter-
acts with pRb [59], which in turn interacts with RBBP,
another member of synphenotype group 6.1.
Another more obvious example of genes falling within the
same synphenotype group and that function in the same
pathway are BMP4, and the molecule that functions down-
stream of this transforming growth factor type b family
member, Smad1 [60]. Signiﬁcantly, MOs directed against
BMP4 and Smad1 can act synergistically, in the sense that
simultaneous expression of low doses of BMP4 and Smad1
MOs causes stronger phenotypes than when the oligonucleo-
tides are injected individually (unpublished data).
Although members of a single synphenotype group may
indeed be involved in the same developmental or molecular
pathway, it is also possible that loss-of-function of different
members of a particular molecular pathway may yield distinct
phenotypes. Thus, although RBBP1 is a member of synphe-
notype group 6.1, its partner pRb is required earlier in
development and is a member of synphenotype group 2.2
(gastrula or neurula defects). Other members of this group
include three novel genes as well as Anillin, Par6B, Rad51,
Table 7. Comparison of Xenopus tropicalis and Zebrafish Phenotypes
Comparison of X. tropicalis and Zebrafish Phenotypes Cases (n ¼ 16
a) Genes
Similar phenotypes 12 Blimp1/Prdm-1/U-boot, Brachyury/Ntl, Chimerin E-cadherin/half-baked,
Frizzled7/Frizzled7a,b, Frizzled8/Frizzled8a,b,c, Lefty-b/Lefty-2/Lefty-1,
Nodal-related 1/Squint, Tbx2/Tbx2a,b, Tbx6/Tbx16/spadetail,
Wnt8/Wnt8a,b, Wnt11/Silberblick
Different phenotypes in X. tropicalis and zebrafish 1 CPSF4/no arches
Phenotype observed in zebrafish but not in X. tropicalis 1 Eomes
Phenotype observed in X. tropicalis but not in zebrafish 1 p53
No embryonic phenotype in either species 5 Cdx1/cdx1a, CPSF1, CPSF3, Fgfr1, HoxB3
aZebrafish phenotype data were retrieved from the Zebrafish Information Network (ZFIN) and the Zebrafish International Resource Center, University of Oregon, Eugene, Oregon, United
States (http://zfin.org).
doi:10.1371/journal.pgen.0020193.t007
Table 6. Comparison of Xenopus tropicalis and Mouse Phenotypes
Comparison of X. tropicalis and Mouse Phenotypes Cases (n ¼ 57) Genes
Similar phenotypes 29 14-3-3e, Blimp1, BMP4, Brachyury, cdx-2, Dp71, E-cadherin, eed, Fgfr3,
Hesx-1(Xanf-1), HoxC8, Lefty-b, Lim1, Mu2, nodal, rad51, Rarb, Rb,
Rb2, SerpinA1 Smad1, Smad2, Smad4, Smad6, Suv39h1, Suv39h2,
Tbx2,Tbx6, vhlh
Different phenotypes in X. tropicalis and mouse 9 14-3-3zeta, Cdc42, dlgh1, frizzled6, Hox7.1, integrinb1, p53, Smad3,Tbx3
Phenotype observed in mouse but not in X. tropicalis 8 Cdx1, D2LIC, Eomes, Fgfr1, Otx2, Rac1, HoxB3, HoxD1
Phenotype observed in X. tropicalis but not in mouse 6 Fgfr4a, Tieg2, frizzled8, frzA, AHNAK, TGIF1
No embryonic phenotype in either species 5 Frizzled10, 53bp1, HBEGF, SerpinE2, OA1
Mouse phenotype data were retrieved from the Mouse Genome Database, Mouse Genome Informatics Web site, The Jackson Laboratory, Bar Harbor, Maine, United States (http://www.
informatics.jax.org).
doi:10.1371/journal.pgen.0020193.t006
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a complex that includes members of the Smad family [61].
The Future
Together, our results suggest that it should be possible to
use MOs together with DNA sequence analyses in X. tropicalis
[24] to perform a large-scale, low-cost, functional screen in a
vertebrate embryo. Such a screen should provide valuable
information about gene function in development and disease,
and by injecting different doses of MOs it should be possible
to study gene dosage effects, thereby creating the equivalent
of an allelic series for each gene product. Although in this
paper we have not been able to address the efﬁcacy of
individual MOs with respect to their ability to depress levels
of the targeted protein, this may be possible in the future by
use of techniques such as iTRAQ [62] or AQUA [63].
Materials and Methods
Embryos and in vitro fertilization. Adult Xenopus tropicalis were
obtained from NASCO (Fort Atkinson, Wisconsin, United States), and
are outbred Nigerian frogs derived from University of Virginia stock.
Females were primed with 10 U pregnant mare serum gonadotrophin
1–5 d before use and they then received 100 U Chorulon 3–4 h before
egg harvesting. Testes were dissected from sacriﬁced males and
macerated in L15 medium containing 10% sheep serum. The sperm
suspension was added to eggs and sperm and was activated 3–4 min
later by ﬂooding with 0.13 MMR. Embryos were de-jellied using 2%
cysteine hydrochloride (pH 7.9–8.1) 8–9 min after ﬂooding and they
were then rinsed in 0.013 MMR prior to injection [64].
MO design and microinjection. MOs were designed to complement
sequence between  80 and þ25 nucleotides of the translation start
site of the target mRNA. We excluded regions containing poly-
morphisms by referring to a clustered full-length gene sequence
database (http://informatics.gurdon.cam.ac.uk/online/xt-ﬂ-db.html)
and then by performing EST searches using the Xenopus tropicalis
EST Blast Server at the Wellcome Trust Sanger Institute, Cambridge,
United Kingdom (http://www.sanger.ac.uk/cgi-bin/blast/submitblast/
x_tropicalis). Morpholinos were designed either by Gene Tools
(Philomath, Oregon, United States) or by following the instructions
outlined at the Gene Tools Web site (http://www.gene-tools.com).
When there were several choices of optimal MO, the sequence closest
to the initiating AUG of the target mRNA was selected. Morpholinos
were modiﬁed by the addition of either Carboxyﬂuorescein or
Lissamine ﬂuorochromes. This allowed us to ensure that all scored
embryos had indeed received injections of MOs and that the MOs
were uniformly distributed throughout the embryo. For each MO
tested, at least 40 X. tropicalis embryos were injected at the one-cell
stage with either 10–15 ng or 30 ng of MO at a concentration of 10 ng/
nl in H2O. The Gene Tools standard control oligonucleotide 59-
CCTCTTACCTCAGTTACAATTTATA 39 was used as a control and
injected at doses of 10–15 ng and 30 ng.
Samples of the MOs used in this study are available on request
while stocks last.
Speciﬁcity and rescue experiments. To test the speciﬁcity of the
phenotypes in the gastrulation synphenotype group, embryos were
injected with MOs (10–15 ng) that differed in ﬁve bases from the
target sequence (details available on request). Rescues were carried
out by using the PCR to create expression constructs that retain the
Kozak sequence of the endogenous mRNA but lack that part of the 59
UTR which is recognized by MO2. In addition, six base changes were
introduced into the region of the mRNA that is recognized by MO1.
Details are available on request.
TUNEL analysis was performed as described previously [65].
Embryos were injected at the one-cell stage with 15 ng speciﬁc MO
or 30 ng of the Gene Tools standard control MO.
Recording of results. Embryos were examined and photographed
at gastrula (stages 10–12), tailbud (stages 24–28), and tadpole (stages
37–41) stages. Samples were ﬁxed in MEMFA (0.1 M MOPS [pH 7.4], 2
mM EGTA, 1 mM MgSO4, and 3.7% formaldehyde) or 4% form-
aldehyde. For a particular MO to be classiﬁed as causing a
‘‘phenotype,’’ we required that its injection should cause at least
50% of embryos (n   40) to develop in a similar abnormal fashion.
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